Skip to content

Human Sperm Markers of Cryodamage Resistance

Molecular Diagnostic of Sperm Cryoresistance of Semen Donors and Clinical Outcomes After Artificial Insemination. Optimization of Sperm Bank

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02535377
Enrollment
40
Registered
2015-08-28
Start date
2015-02-12
Completion date
2019-12-12
Last updated
2021-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility

Keywords

Cryodamage, microarrays, Insemination, sperm

Brief summary

Sperm freezing has been employed for decades for male fertility preservation in cases of foreseeable or unexpected loss of fertility to guarantee future paternity, and also as a complement of assisted reproduction techniques. Sperm quality after thawing is highly variable, even among consecutive samples from the same individual, with mean survival rates around 40%. To date, the molecular basis of the adequate resistance or intolerance to freezing/thawing protocols is unknown, and its knowledge can lead to improvement in the selection of the samples to be frozen and also in the adequate supplement of cryopreservation media. Microarray analysis provides a powerful tool to address the molecular explanation beyond this behaviour, yielding results about comparative messenger ribonucleic acid (mRNA)expression under the two different biological conditions: optimal and suboptimal survival. Then, the aim of the investigators' study is to determine the genomic profile of sperm samples depending on their survival resistance to cryopreservation, to determine genes involved in cryodamage sensitivity.

Detailed description

Nested cases and controls design, with donor sperm samples frozen under conventional protocols, categorized depending on their good (GSR, n=20) (less than 20% motility decrease) or bad (BSR, n=20) (more than 20% motility decrease) survival rates. Sperm mRNA was extracted using Trizol protocol, suspended in diethylpyrocarbonate (DEPC)-treated water and frozen at -80 degrees until the microarray experiments were performed. RNAs were analyzed on Agilent Bioanalyzer 2100. Samples were pooled in 4 (5 samples/pool and 4 pools/group). Finally, 8 Agilent One colour Whole genome microarray (44K) were performed with pooled samples, 4 microarrays per group. The results will be evaluate to detect those genes differentially expressed.

Interventions

OTHERSperm cryopreservation

Sperm from the different groups are cryopreserved to evaluate their resistance to preservation.

Sponsors

Igenomix
CollaboratorINDUSTRY
Instituto Valenciano de Infertilidad, IVI Alicante
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

The criteria used for the inclusion of donors in the sperm bank will be considered: * males from 18 to 35 years. * good physical and psychological conditions and no hereditary diseases * seminal parameters: concentration \> 40 million sperm / ml; percentage of progressive motility\> 50% percentage of normal forms\> 4%. * For pregnancy rates after artificial insemination, only women\< 40 years without tubal pathologies and artificial insemination indications will be included.

Exclusion criteria

All the population not included in the list of inclusion will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Genomic profile of sperm samples depending on their survival resistance to cryopreservationA year and a halfThe genomic profile of sperm samples depending on their survival resistance to cryopreservation will be analysed and expressed as: * Common or differentially expressed genes: in case of genes expressed in both groups * Exclusive Genes, in case of genes expressed just in one group

Secondary

MeasureTime frameDescription
Pregnancy rates after artificial insemination with donor semen in the different groups.two yearsOnce obtained the genomic profile of samples from donors included the different groups, we will analyze its relationship with the reproductive outcomes, in particular pregnancy rates after conventional artificial insemination (percentage of positive pregnancy test)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026